Search

everythinglearnresearchcommunity

for

Search:↓

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Men using steroids or finasteride to look more attractive may harm their fertility and sexual function, creating a paradox where they seem fit but may be less able to reproduce.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Follicular Unit Extraction (FUE) is a popular hair transplant method with minimal scarring that can transplant many grafts quickly and improve appearance and psychological well-being.

New cell-based therapies may improve hair loss treatments in the future.

Hair loss in postmenopausal woman caused by ovarian issue.

Some people with chronic hair loss may have thyroid autoimmunity.

Normal hair thickness varies by scalp area and a mix of hair thicknesses is typical in healthy individuals.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

Gene differences may affect baldness treatment response in Korean men.

Dermal papilla cells are key for hair growth and could help us understand and treat hair loss.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Too much androgen can cause hair loss; finasteride may help.

5% topical minoxidil can cause severe body hair growth, which disappears after stopping treatment.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Hair follicle culture helps develop new treatments for hair loss.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Hair from balding and non-balding areas regrows similarly on mice.

Hair restoration combines drugs and follicular unit grafting for natural, long-lasting results.

Platelet-rich plasma may improve hair density in androgenetic alopecia patients.

Combining intradermotherapy with microneedling and a topical solution reduces hair loss more effectively than intradermotherapy alone.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Hair loss linked to higher heart disease risk in both men and women.

Male baldness is not significantly associated with coronary artery disease.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.